GYRE is Gyre Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $6.86. Market cap: $727M. Capital Quality Rank: 95/100 — Market alpha.
Stock snapshot
| Price | $6.86 |
| Market cap | $727M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 95 / 100 · Market alpha |
| ROIC (TTM) | 87.7% |
| Shareholder buyback yield | -0.86% |
| Altman Z-score zone | Safe |
About GYRE
Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.
Related non-dividend companies
Other non-dividend stocks investors research alongside GYRE. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is GYRE's current stock price?
GYRE (Gyre Therapeutics, Inc.) is currently trading at $6.86.
Does GYRE pay a dividend?
GYRE (Gyre Therapeutics, Inc.) does not currently pay a regular dividend.
What is GYRE's Capital Quality Rank?
GYRE has a Capital Quality Rank of 95/100 — Market alpha. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track GYRE in DiviDrip
Add GYRE to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search GYRE and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.